Return to the home page of D-is-for-Diabetes

Advertisement

 







 

Dr. Bill's Commentaries

FDA Warns Of Possible Link Of Byetta To Acute Pancreatitis   (October 17, 2007)

Following is posted at the FDA website:

FDA ALERT [10/2007]: FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta, a drug used to treat adults with type 2 diabetes. An association between Byetta and acute pancreatitis is suspected in some of these cases.

Healthcare professionals should instruct patients taking Byetta to seek prompt medical care if they experience unexplained persistent severe abdominal pain which may or may not be accompanied by vomiting. If pancreatitis is suspected, Byetta should be discontinued. If pancreatitis is confirmed, Byetta should not be restarted unless an alternative etiology is identified.

FDA has asked and the maker of Byetta, Amylin Pharmaceuticals, Inc. has agreed to include information about acute pancreatitis in the PRECAUTIONS section of the product label.
What to do?

  1. Don't stop your Byetta if you're taking it simply because of this warning, unless your blood tests are positive for pancreatitis!
  2. Since gut side effects are common with Byetta, and your doctor probably has had dozens or hundreds of people calling about tummy upsets on this drug, you'll have to push your doc -- ask him/her to read the FDA warning.
  3. Ask for a pair of blood tests called "amylase and lipase" to confirm or rule out pancreatitis.
  4. And finally, if you've had acute pancreatitis while on Byetta, be sure your physician reports your case to the manufacturer and/or the FDA.
        go to the top of this page

Advertisement

Dr. Bill Quick began writing at HealthCentral's diabetes website in November, 2006. These essays are reproduced at D-is-for-Diabetes with the permission of HealthCentral.



Return to listing of Dr. Bill's Commentaries

This page was new at D-is-for-Diabetes on March 26, 2012

go to the top of this page go to home page read about us contact us read our disclaimer read our privacy policy search our website go to the site map find out what's new